Elevated levels of HSP110 have been detected in numerous cancer types, suggesting that it is a potential therapeutic target for various cancers, including melanoma, colorectal cancer, and non-Hodgkin lymphoma [192,193]. This evidence concerns the gene HSPH1 and melanoma.